PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression
Numerous diseases have been connected to protein arginine methylations mediated by protein arginine methyltransferase 5 (PRMT5). Clinical investigations of the PRMT5-specific inhibitor GSK3326595 are currently being conducted, and the results are promising for preventing cancers. However, the detail...
Saved in:
| Main Authors: | Sen Meng, Hao Liu, Jiayu Xu, Chuyin Deng, Xingyou Qian, Sufang Chu, Wei-Guo Zhu, Jiuling Zhu, Hongmei Yong, Zhongwei Li, Jin Bai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Research |
| Online Access: | https://spj.science.org/doi/10.34133/research.0549 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRMT5-Mediated Arginine Methylation of ACSL4 Attenuates Its Stability and Suppresses Ferroptosis in Renal Cancer
by: Meng Zhang, et al.
Published: (2025-01-01) -
PRMT5 highly expressed on CD16 + CD56- natural killer cells is correlated with NK cells exhaustion in colorectal cancer mesenchyme
by: Zunzhen Nie, et al.
Published: (2025-03-01) -
PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop
by: Fan Yang, et al.
Published: (2025-06-01) -
M6A Methylation Regulators METTL3 and ALKBH5 are Risk Factors for EGFR-Mutant NSCLC
by: Yaofeng Zhi MMed, et al.
Published: (2025-05-01) -
The methyltransferases PRMT4/CARM1 and PRMT5 control differentially myogenesis in zebrafish.
by: Julie Batut, et al.
Published: (2011-01-01)